Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,812 signal articles · 260 in last 24h · 118,244 total before filter · latest 35m ago
260last 24h
1577last 7d
251● bullish (7d)
161● bearish (7d)
205publishers
AllMacro303Earnings636M&A97Regulatory28Product14Analyst24
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Sanofi Q2 Earnings Call Highlights
MarketBeat19d agoneutral
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicines and cost discipline. The company also increased its 2030 sales ambition for Dupixent to approximately €25 billion while outlining an ongo